mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.009 |
mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |
mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.02 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
blebbistatin |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.02 |